ReposiTrak Financials
This page shows ReposiTrak (TRAK) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
ReposiTrak has an operating margin of 27.6%, meaning the company retains $28 of operating profit per $100 of revenue. This strong profitability earns a score of 83/100, reflecting efficient cost management and pricing power. This is up from 24.6% the prior year.
ReposiTrak's revenue grew 10.5% year-over-year to $22.6M, a solid pace of expansion. This earns a growth score of 51/100.
ReposiTrak carries a low D/E ratio of 0.01, meaning only $0.01 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 6.09, ReposiTrak holds $6.09 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.
ReposiTrak converts 37.2% of revenue into free cash flow ($8.4M). This strong cash generation earns a score of 100/100.
ReposiTrak's ROE of 14.1% shows moderate profitability relative to equity, earning a score of 42/100. This is up from 12.7% the prior year.
ReposiTrak scores 15.28, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($137.6M) relative to total liabilities ($5.8M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
ReposiTrak passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, ReposiTrak generates $1.21 in operating cash flow ($8.4M OCF vs $7.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
ReposiTrak earns $127.9 in operating income for every $1 of interest expense ($6.2M vs $49K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
ReposiTrak generated $22.6M in revenue in fiscal year 2025. This represents an increase of 10.5% from the prior year.
ReposiTrak's EBITDA was $7.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 20.4% from the prior year.
ReposiTrak reported $7.0M in net income in fiscal year 2025. This represents an increase of 17.1% from the prior year.
ReposiTrak earned $0.35 per diluted share (EPS) in fiscal year 2025. This represents an increase of 20.7% from the prior year.
Cash & Balance Sheet
ReposiTrak generated $8.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 22.0% from the prior year.
ReposiTrak held $28.6M in cash against $279K in long-term debt as of fiscal year 2025.
ReposiTrak had 18M shares outstanding in fiscal year 2025. This represents an increase of 0.3% from the prior year.
Margins & Returns
ReposiTrak's gross margin was 83.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.4 percentage points from the prior year.
ReposiTrak's operating margin was 27.6% in fiscal year 2025, reflecting core business profitability. This is up 3.0 percentage points from the prior year.
ReposiTrak's net profit margin was 30.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.7 percentage points from the prior year.
ReposiTrak's ROE was 14.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.4 percentage points from the prior year.
Capital Allocation
ReposiTrak spent $200K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 86.8% from the prior year.
ReposiTrak invested $16K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 78.2% from the prior year.
TRAK Income Statement
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.9M0.0% | $5.9M-1.9% | $6.0M+3.7% | $5.8M-2.6% | $5.9M+7.7% | $5.5M+0.9% | $5.4M+5.0% | $5.2M |
| Cost of Revenue | $854K0.0% | $854K0.0% | $854K-5.9% | $908K-0.4% | $912K-9.1% | $1.0M+16.7% | $859K+1.7% | $845K |
| Gross Profit | $5.0M0.0% | $5.0M-2.2% | $5.1M+5.5% | $4.9M-3.0% | $5.0M+11.4% | $4.5M-2.0% | $4.6M+5.6% | $4.3M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $1.5M0.0% | $1.5M+7.0% | $1.4M-7.2% | $1.5M+1.5% | $1.5M+5.7% | $1.4M+6.5% | $1.3M-4.4% | $1.4M |
| Operating Income | $1.8M0.0% | $1.8M-4.1% | $1.9M+19.4% | $1.6M-12.3% | $1.8M+33.8% | $1.4M-8.6% | $1.5M+12.0% | $1.3M |
| Interest Expense | $9K0.0% | $9K-16.9% | $11K-17.0% | $14K+6.5% | $13K+6.5% | $12K+18.3% | $10K+63.8% | $6K |
| Income Tax | $450K0.0% | $450K0.0% | $450K+101.1% | $224K+49.3% | $150K-1.4% | $152K+1.4% | $150K+50.0% | $100K |
| Net Income | $1.7M0.0% | $1.7M-7.3% | $1.8M+1.3% | $1.8M-8.6% | $2.0M+26.7% | $1.6M-6.9% | $1.7M+5.5% | $1.6M |
| EPS (Diluted) | $0.090.0% | $0.090.0% | $0.09 | N/A | $0.10+25.0% | $0.080.0% | $0.08 | N/A |
TRAK Balance Sheet
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | N/A | $56.3M+1.3% | $55.6M+0.5% | $55.3M+0.9% | $54.8M+0.2% | $54.7M+4.6% | $52.3M+1.4% | $51.6M |
| Current Assets | N/A | $35.0M+2.5% | $34.1M+1.3% | $33.7M+2.8% | $32.8M+1.1% | $32.4M+7.7% | $30.1M+2.7% | $29.3M |
| Cash & Equivalents | N/A | $28.7M-0.3% | $28.8M+0.8% | $28.6M+1.5% | $28.1M+0.3% | $28.0M+8.7% | $25.8M+2.5% | $25.2M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | $4.9M+11.8% | $4.3M+5.0% | $4.1M+14.8% | $3.6M+6.7% | $3.4M+2.3% | $3.3M-10.3% | $3.7M |
| Goodwill | N/A | $20.9M0.0% | $20.9M0.0% | $20.9M0.0% | $20.9M0.0% | $20.9M0.0% | $20.9M0.0% | $20.9M |
| Total Liabilities | N/A | $6.6M+21.2% | $5.4M-6.4% | $5.8M-1.8% | $5.9M-13.1% | $6.8M+41.6% | $4.8M+1.3% | $4.7M |
| Current Liabilities | N/A | $6.4M+23.1% | $5.2M-5.7% | $5.5M+1.8% | $5.4M-13.1% | $6.3M+40.3% | $4.5M-1.9% | $4.5M |
| Long-Term Debt | N/A | $170K-24.3% | $225K-19.3% | $279K-16.0% | $332K-13.6% | $384K+131.8% | $166K | $0 |
| Total Equity | N/A | $49.7M-0.9% | $50.2M+1.3% | $49.5M+1.2% | $48.9M+2.1% | $47.9M+0.9% | $47.5M+1.4% | $46.9M |
| Retained Earnings | N/A | -$10.3M+10.7% | -$11.5M+10.5% | -$12.8M+9.5% | -$14.2M+9.6% | -$15.7M+6.4% | -$16.8M+6.7% | -$18.0M |
TRAK Cash Flow Statement
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.8M+68.7% | $2.2M+45.5% | $1.5M-7.1% | $1.7M+15.5% | $1.4M-58.5% | $3.5M+85.1% | $1.9M-9.0% | $2.1M |
| Capital Expenditures | $12K+1175000.0% | -$1-100.0% | $12K+63.9% | $7K-18.5% | $9K | $0 | $0-100.0% | $56K |
| Free Cash Flow | $3.8M+68.2% | $2.2M+46.6% | $1.5M-7.4% | $1.6M+15.7% | $1.4M-58.8% | $3.5M+85.1% | $1.9M-6.5% | $2.0M |
| Investing Cash Flow | $20K+96747.6% | $21+100.1% | -$20K-231.3% | -$6K+51.0% | -$13K+17.5% | -$15K-144.6% | $34K+165.3% | -$52K |
| Financing Cash Flow | $3.6M+255.5% | -$2.3M-80.1% | -$1.3M-6.2% | -$1.2M+8.5% | -$1.3M-11.4% | -$1.2M+5.8% | -$1.3M+2.6% | -$1.3M |
| Dividends Paid | $827K+94.9% | $424K+5.4% | $403K+28.3% | $314K-38.4% | $510K+24.8% | $409K-3.3% | $423K-2.8% | $435K |
| Share Buybacks | $1.2M+13.7% | $1.1M+632.5% | $150K+50.0% | $100K | $0-100.0% | $100K | $0 | $0 |
TRAK Financial Ratios
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 85.4%0.0pp | 85.4%-0.3pp | 85.7%+1.5pp | 84.2%-0.3pp | 84.6%+2.8pp | 81.7%-2.5pp | 84.2%+0.5pp | 83.7% |
| Operating Margin | 31.0%0.0pp | 31.0%-0.7pp | 31.7%+4.2pp | 27.5%-3.1pp | 30.6%+6.0pp | 24.6%-2.6pp | 27.2%+1.7pp | 25.5% |
| Net Margin | 28.8%0.0pp | 28.8%-1.7pp | 30.5%-0.7pp | 31.2%-2.1pp | 33.2%+5.0pp | 28.2%-2.4pp | 30.6%+0.2pp | 30.4% |
| Return on Equity | N/A | 3.4%-0.2pp | 3.6%0.0pp | 3.6%-0.4pp | 4.0%+0.8pp | 3.2%-0.3pp | 3.5%+0.1pp | 3.4% |
| Return on Assets | N/A | 3.0%-0.3pp | 3.3%+0.0pp | 3.3%-0.3pp | 3.6%+0.8pp | 2.8%-0.4pp | 3.2%+0.1pp | 3.1% |
| Current Ratio | N/A | 5.45-1.1 | 6.54+0.5 | 6.09+0.1 | 6.03+0.8 | 5.18-1.6 | 6.75+0.3 | 6.45 |
| Debt-to-Equity | N/A | 0.000.0 | 0.000.0 | 0.010.0 | 0.010.0 | 0.010.0 | 0.000.0 | 0.00 |
| FCF Margin | 64.3%+26.1pp | 38.2%+12.7pp | 25.6%-3.1pp | 28.6%+4.5pp | 24.1%-38.9pp | 63.0%+28.7pp | 34.4%-4.2pp | 38.6% |
Similar Companies
Frequently Asked Questions
What is ReposiTrak's annual revenue?
ReposiTrak (TRAK) reported $22.6M in total revenue for fiscal year 2025. This represents a 10.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is ReposiTrak's revenue growing?
ReposiTrak (TRAK) revenue grew by 10.5% year-over-year, from $20.5M to $22.6M in fiscal year 2025.
Is ReposiTrak profitable?
Yes, ReposiTrak (TRAK) reported a net income of $7.0M in fiscal year 2025, with a net profit margin of 30.9%.
What is ReposiTrak's EBITDA?
ReposiTrak (TRAK) had EBITDA of $7.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does ReposiTrak have?
As of fiscal year 2025, ReposiTrak (TRAK) had $28.6M in cash and equivalents against $279K in long-term debt.
What is ReposiTrak's gross margin?
ReposiTrak (TRAK) had a gross margin of 83.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is ReposiTrak's operating margin?
ReposiTrak (TRAK) had an operating margin of 27.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is ReposiTrak's net profit margin?
ReposiTrak (TRAK) had a net profit margin of 30.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is ReposiTrak's return on equity (ROE)?
ReposiTrak (TRAK) has a return on equity of 14.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is ReposiTrak's free cash flow?
ReposiTrak (TRAK) generated $8.4M in free cash flow during fiscal year 2025. This represents a 22.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is ReposiTrak's operating cash flow?
ReposiTrak (TRAK) generated $8.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are ReposiTrak's total assets?
ReposiTrak (TRAK) had $55.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What are ReposiTrak's capital expenditures?
ReposiTrak (TRAK) invested $16K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is ReposiTrak's current ratio?
ReposiTrak (TRAK) had a current ratio of 6.09 as of fiscal year 2025, which is generally considered healthy.
What is ReposiTrak's debt-to-equity ratio?
ReposiTrak (TRAK) had a debt-to-equity ratio of 0.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is ReposiTrak's return on assets (ROA)?
ReposiTrak (TRAK) had a return on assets of 12.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is ReposiTrak's Altman Z-Score?
ReposiTrak (TRAK) has an Altman Z-Score of 15.28, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is ReposiTrak's Piotroski F-Score?
ReposiTrak (TRAK) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are ReposiTrak's earnings high quality?
ReposiTrak (TRAK) has an earnings quality ratio of 1.21x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can ReposiTrak cover its interest payments?
ReposiTrak (TRAK) has an interest coverage ratio of 127.9x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is ReposiTrak?
ReposiTrak (TRAK) scores 79 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.